October 20, 2017 8:46 PM ET

Pharmaceuticals

Company Overview of Kalos Therapeutics, Inc.

Key Executives for Kalos Therapeutics, Inc.

NameBoard RelationshipsTitleAge
George E. Colberg No RelationshipsCo-Founder, Chief Executive Officer and Director--
James A. Merritt M.D.2 RelationshipsPresident and Chief Medical Officer65
Daniel Douglas Von Hoff M.D., F.A.C.P.473 RelationshipsChief Scientific Officer of US Oncology69
Michael R. Kozlowski Ph.D., OD No RelationshipsChief Scientific Officer--

Kalos Therapeutics, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Larry G. Stambaugh 20 RelationshipsRubicon Venture Capital70
John M. Evey 17 RelationshipsEnvision Solar International, Inc.67
View All Board Members

Kalos Therapeutics, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
378.3K
Bonus
412.6K
Total Short Term Compensation
524.6K
Total Value of Options
8.0M
Compensation as of Fiscal Year
Kalos Therapeutics, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Bayer Appoints Jennifer Brendel to Vice President of Communications for the Consumer Health Division in the United States
October 19, 2017 2:10 PM ET
Pharmaxis Announces Executive Appointments
October 19, 2017 1:25 AM ET
The Hydroponics Company Limited Announces Management Changes
October 18, 2017 11:45 PM ET
Desh Rakshak Aushdhalaya Limited Announces Resignation of Harsh Agarwal as Company Secretary
October 18, 2017 12:54 PM ET
Depomed Announces Appointment of Santosh J. Vetticaden as Senior Vice President, Chief Medical and Scientific Officer
October 18, 2017 12:00 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Kalos Therapeutics, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.